×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

CinCor Pharma Inc. (CINC) NASDAQ

$29.06 (0.14) (-0.48%)

Market Cap: -

As of 02/23/23 04:00 PM EST. Market closed.

(CINC)

CinCor Pharma Inc. (CINC)
NASDAQ

$29.06
(0.14) (-0.48%)

Market Cap: -

As of 02/23/23 04:00 PM EST. Market closed.

Add to Portfolio

CinCor Pharma Inc. is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. The companys focus is on cardiovascular, metabolic and kidney diseases. CinCor Pharma was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in ... read more

CinCor Pharma Inc. is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. The companys focus is on cardiovascular, metabolic and kidney diseases. CinCor Pharma was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in 2018. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Marc de Garidel
Full Time Employees
21
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Marc de Garidel
Full Time Employees
21
Address
.
PRICE CHART FOR CINCOR PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$29.20
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
43,764,323
Open
-
Previous Close
$29.20
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
43,764,323
FINANCIAL STATEMENTS FOR CINCOR PHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CINCOR PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
HEALY JAMESDirectorNov 28, 2022 Sale$14.326,00085,9200Feb 27, 2023, 09:15 PM
Freeman MasonChief Medical OfficerJun 10, 2022 Sale$15.216912,494Feb 27, 2023, 05:10 PM
Pearce CatherineChief Operating OfficerJan 11, 2023 Option Exercise$28.753,997114,914140,149Jan 19, 2023, 04:34 PM
5AM Partners VI, LLC10% OwnerAug 15, 2022 Buy$30.00112,6673,380,0103,953,990Aug 17, 2022, 08:01 PM
5AM Partners VI, LLC10% OwnerAug 15, 2022 Buy$30.00487,33314,619,990487,333Aug 17, 2022, 08:01 PM
Sofinnova Partners SAS10% OwnerAug 15, 2022 Buy$30.00133,3333,999,9904,220,979Aug 17, 2022, 04:19 PM
Sofinnova Venture Partners X, L.P.10% OwnerAug 11, 2022 Buy$30.00500,00015,000,0006,073,949Aug 15, 2022, 03:46 PM
HEALY JAMESDirectorAug 11, 2022 Buy$30.006,000180,0006,000Aug 15, 2022, 03:45 PM
HEALY JAMESDirectorAug 11, 2022 Buy$30.00500,00015,000,0006,073,949Aug 15, 2022, 03:45 PM
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.10% OwnerAug 11, 2022 Buy$30.0083,0002,490,0004,209,470Aug 15, 2022, 02:22 PM
GENERAL ATLANTIC, L.P.10% OwnerAug 11, 2022 Buy$30.0083,0002,490,0004,209,470Aug 15, 2022, 02:21 PM
HEALY JAMESDirectorAug 05, 2022 Option Exercise$13.6029,411399,99029,411Aug 08, 2022, 12:57 PM
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.10% OwnerJan 11, 2022 Buy$16.001,700,00027,200,0004,126,470Jan 13, 2022, 09:32 PM
GENERAL ATLANTIC, L.P.10% OwnerJan 11, 2022 Buy$16.001,700,00027,200,0004,126,470Jan 13, 2022, 09:32 PM
5AM Partners VI, LLC10% OwnerJan 11, 2022 Buy$16.00312,5005,000,000496,323Jan 13, 2022, 04:45 PM
5AM Partners VI, LLC10% OwnerJan 11, 2022 Buy$16.00157,5002,520,0003,841,323Jan 13, 2022, 04:45 PM
Sofinnova Venture Partners X, L.P.10% OwnerJan 11, 2022 Buy$16.00325,0005,200,0005,573,949Jan 13, 2022, 04:38 PM
Sofinnova Partners SAS10% OwnerJan 11, 2022 Buy$16.00220,0003,520,0004,087,646Jan 13, 2022, 04:36 PM
HEALY JAMESDirectorJan 11, 2022 Buy$16.00325,0005,200,0005,573,949Jan 13, 2022, 04:33 PM
Pearce CatherineChief Operating OfficerJan 11, 2022 Buy$16.001,50024,0001,500Jan 13, 2022, 04:31 PM
Pearce CatherineChief Operating OfficerJan 11, 2022 Buy$16.0075012,000130,911Jan 13, 2022, 04:31 PM
Freeman MasonEVP Clinical DevelopmentJan 11, 2022 Buy$16.001001,600100Jan 13, 2022, 04:28 PM
Freeman MasonEVP Clinical DevelopmentJan 11, 2022 Buy$16.002,50040,0002,500Jan 13, 2022, 04:28 PM
de Garidel MarcChief Executive OfficerJan 11, 2022 Buy$16.0012,500200,00012,500Jan 13, 2022, 04:26 PM
Coelho Mary TheresaEVP CFO & Chief BD OfficerJan 11, 2022 Buy$16.001001,600100Jan 13, 2022, 04:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
HEALY JAMESDirector11/28/202285,920
Freeman MasonChief Medical Officer06/10/202291
Pearce CatherineChief Operating Officer01/11/2023114,914
5AM Partners VI, LLC10% Owner08/15/20223,380,010
5AM Partners VI, LLC10% Owner08/15/202214,619,990
Sofinnova Partners SAS10% Owner08/15/20223,999,990
Sofinnova Venture Partners X, L.P.10% Owner08/11/202215,000,000
HEALY JAMESDirector08/11/2022180,000
HEALY JAMESDirector08/11/202215,000,000
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.10% Owner08/11/20222,490,000
GENERAL ATLANTIC, L.P.10% Owner08/11/20222,490,000
HEALY JAMESDirector08/05/2022399,990
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.10% Owner01/11/202227,200,000
GENERAL ATLANTIC, L.P.10% Owner01/11/202227,200,000
5AM Partners VI, LLC10% Owner01/11/20225,000,000
5AM Partners VI, LLC10% Owner01/11/20222,520,000
Sofinnova Venture Partners X, L.P.10% Owner01/11/20225,200,000
Sofinnova Partners SAS10% Owner01/11/20223,520,000
HEALY JAMESDirector01/11/20225,200,000
Pearce CatherineChief Operating Officer01/11/202224,000
Pearce CatherineChief Operating Officer01/11/202212,000
Freeman MasonEVP Clinical Development01/11/20221,600
Freeman MasonEVP Clinical Development01/11/202240,000
de Garidel MarcChief Executive Officer01/11/2022200,000
Coelho Mary TheresaEVP CFO & Chief BD Officer01/11/20221,600
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR CINCOR PHARMA INC
LOADING...